Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05678231 · ClinicalTrials.gov registry record · NA

Zero Degree Knee Positioner for Improved Earley Knee Extension Following Total Knee Arthroplasty

A NA study of Osteoarthritis, Knee, sponsored by Prisma Health-Midlands.

Active
Registry status
NA
Development phase
154
Enrollment target
1
Study location

NCT05678231: Active NA study of Osteoarthritis, Knee, sponsored by Prisma Health-Midlands.

NCT05678231 is a NA study of Osteoarthritis, Knee that is active but no longer recruiting, run by Prisma Health-Midlands. The registered enrollment target is 154 participants, below the 496-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05678231, a NA study of Osteoarthritis, Knee, is active but no longer recruiting, sponsored by Prisma Health-Midlands.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
154 participants
Enrollment target
1
Study location

Study Summary

Studies have demonstrated that early rehabilitation interventions following knee arthroplasty (TKA) can shorten the time needed to regain baseline extension/full extension and gait mechanics. As telehealth visits and home-based rehabilitation increases with advancements in technology, much of this rehabilitation is projected to be performed at home. The purpose of this study is to prospectively evaluate early post-operative knee extension and self-reported outcomes in patients using the Zero Degree Knee positioner (ZDK) compared to subjects not using the ZDK. Patients electing to undergo primary TKA will be recruited into the study and randomized to receive and follow the ZDK protocol post-operatively or standard of care rehabilitation instructions. Knee extension measurements will be recorded at 2 weeks post-op and patient-reported outcome measurements will be recorded pre-operatively and at various post-op timepoints.

Primary Outcome

The degree of knee extension at the 2 week post-operative visit will be measured via lateral radiograph interpreted by an orthopedic surgeon.

Conditions Studied

Interventions

  • DEVICE Zero Degree Knee Positioner

Study Locations (1)

South Carolina

  • Prisma Health - Midlands - Columbia

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2023-02-10
Est. Completion 2026-06-30
Phase NA
Prisma Health-Midlands

7 total trials

What the registry record for NCT05678231 still lists

NCT05678231 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 496-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Zero Degree Knee Positioner is the first listed.

NCT05678231 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT05678231 about?

NCT05678231 is a clinical study titled "Zero Degree Knee Positioner for Improved Earley Knee Extension Following Total Knee Arthroplasty". Studies have demonstrated that early rehabilitation interventions following knee arthroplasty (TKA) can shorten the time needed to regain baseline extension/full extension and gait mechanics. As telehealth visits and home-based rehabilitation increases with advancements in technology, much of this r...

What is the current status of trial NCT05678231?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 154 participants. The study started on 2023-02-10. Estimated completion is 2026-06-30.

What conditions does trial NCT05678231 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT05678231?

The interventions under investigation include: Zero Degree Knee Positioner (DEVICE).

Who is sponsoring clinical trial NCT05678231?

This trial is sponsored by Prisma Health-Midlands, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05678231 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05678231's enrollment target sits among peer trials

154 42nd of 112 higher than 71 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05678231, the US trial registry maintained by the National Library of Medicine. NCT05678231 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.